Emerging Therapies and Therapeutic Targets for Composite Liver Disease: NASH.
Sobhia ME, Kumari S, Kumar H, Gandhe A, Kaushik D, Kumar H, Jain J, Ankita, Mallick M, Pavani B, Moudgil M, Patel D.
Sobhia ME, et al.
Curr Top Med Chem. 2023;23(21):2027-2047. doi: 10.2174/1568026623666230714113808.
Curr Top Med Chem. 2023.
PMID: 37455455
Review.